155 related articles for article (PubMed ID: 20735721)
1. Mechanisms of factor VIIa-catalyzed activation of factor VIII.
Soeda T; Nogami K; Matsumoto T; Ogiwara K; Shima M
J Thromb Haemost; 2010 Nov; 8(11):2494-503. PubMed ID: 20735721
[TBL] [Abstract][Full Text] [Related]
2. Factor VIII activation by factor VIIa analog (V158D/E296V/M298Q) in tissue factor-independent mechanisms.
Ogiwara K; Nogami K; Shima M
Thromb Haemost; 2011 Oct; 106(4):665-74. PubMed ID: 21901232
[TBL] [Abstract][Full Text] [Related]
3. The role of proteolytic cleavage at Arg
Nakajima Y; Nogami K
Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130501. PubMed ID: 37925034
[TBL] [Abstract][Full Text] [Related]
4. Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.
Furukawa S; Nogami K; Ogiwara K; Shima M
Int J Hematol; 2019 Apr; 109(4):390-401. PubMed ID: 30756344
[TBL] [Abstract][Full Text] [Related]
5. Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII.
Yada K; Nogami K; Ogiwara K; Shibata M; Shima M
Thromb Haemost; 2011 Jun; 105(6):989-98. PubMed ID: 21437361
[TBL] [Abstract][Full Text] [Related]
6. Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.
Kamikubo Y; Mendolicchio GL; Zampolli A; Marchese P; Rothmeier AS; Orje JN; Gale AJ; Krishnaswamy S; Gruber A; Østergaard H; Petersen LC; Ruf W; Ruggeri ZM
Blood; 2017 Oct; 130(14):1661-1670. PubMed ID: 28729433
[TBL] [Abstract][Full Text] [Related]
7. A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor.
Ferrière S; Kawecki C; Ottavi JF; Denis CV; Kauskot A; Christophe OD; Lenting PJ
J Thromb Haemost; 2019 Dec; 17(12):2035-2046. PubMed ID: 31423724
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
[TBL] [Abstract][Full Text] [Related]
9. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
Warren DL; Morrissey JH; Neuenschwander PF
Biochemistry; 1999 May; 38(20):6529-36. PubMed ID: 10350471
[TBL] [Abstract][Full Text] [Related]
10. Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa.
Rao LV; Rapaport SI
Blood; 1990 Mar; 75(5):1069-73. PubMed ID: 2306514
[TBL] [Abstract][Full Text] [Related]
11. Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor.
Persson E; Nielsen LS; Olsen OH
Biochemistry; 2001 Mar; 40(11):3251-6. PubMed ID: 11258943
[TBL] [Abstract][Full Text] [Related]
12. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.
Bergum PW; Cruikshank A; Maki SL; Kelly CR; Ruf W; Vlasuk GP
J Biol Chem; 2001 Mar; 276(13):10063-71. PubMed ID: 11139576
[TBL] [Abstract][Full Text] [Related]
13. Binding of Zn2+ to a Ca2+ loop allosterically attenuates the activity of factor VIIa and reduces its affinity for tissue factor.
Petersen LC; Olsen OH; Nielsen LS; Freskgård PO; Persson E
Protein Sci; 2000 May; 9(5):859-66. PubMed ID: 10850795
[TBL] [Abstract][Full Text] [Related]
14. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
Persson E; Olsen OH
FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
[TBL] [Abstract][Full Text] [Related]
15. Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance.
Björquist P; Boström S
Thromb Res; 1997 Feb; 85(3):225-36. PubMed ID: 9058497
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor alters the pK(a) values of catalytically important factor VIIa residues.
Neuenschwander PF; Vernon JT; Morrissey JH
Biochemistry; 2002 Mar; 41(10):3364-71. PubMed ID: 11876644
[TBL] [Abstract][Full Text] [Related]
17. Structural modulation of factor VIIa by full-length tissue factor (TF
Prasad R; Sen P
J Biomol Struct Dyn; 2018 Feb; 36(3):621-633. PubMed ID: 28150568
[TBL] [Abstract][Full Text] [Related]
18. Analysis of factor VIIa binding to relipidated tissue factor by surface plasmon resonance.
Sen P; Neuenschwander PF; Pendurthi UR; Rao LV
Blood Coagul Fibrinolysis; 2010 Jun; 21(4):376-9. PubMed ID: 20305542
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor.
Sen P; Komissarov AA; Florova G; Idell S; Pendurthi UR; Vijaya Mohan Rao L
J Thromb Haemost; 2011 Mar; 9(3):531-9. PubMed ID: 21143380
[TBL] [Abstract][Full Text] [Related]
20. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
